These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 38042663)
1. Whether the watch-and-wait strategy has application value for rectal cancer with clinical complete response after neoadjuvant chemoradiotherapy? A network meta-analysis. Du R; Chang Y; Zhang J; Cheng Y; Li Y; Zhang C; Zhang J; Xu L; Liu Y Asian J Surg; 2024 Feb; 47(2):853-863. PubMed ID: 38042663 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of the "watch-and-wait" approach for rectal cancer with clinical complete response after neoadjuvant chemoradiotherapy: a meta-analysis. Zhang X; Ding R; Li J; Wu T; Shen Z; Li S; Zhang Y; Dong C; Shang Z; Zhou H; Li T; Li G; Li Y Surg Endosc; 2022 Apr; 36(4):2233-2244. PubMed ID: 34981233 [TBL] [Abstract][Full Text] [Related]
3. Oncologic outcomes of watch-and-wait strategy or surgery for low to intermediate rectal cancer in clinical complete remission after adjuvant chemotherapy: a systematic review and meta-analysis. Tan S; Gao Q; Cui Y; Ou Y; Huang S; Feng W Int J Colorectal Dis; 2023 Oct; 38(1):246. PubMed ID: 37787779 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of wait and see strategy versus radical surgery and local excision for rectal cancer with cCR response after neoadjuvant chemoradiotherapy: a meta-analysis. Zhao GH; Deng L; Ye DM; Wang WH; Yan Y; Yu T World J Surg Oncol; 2020 Aug; 18(1):232. PubMed ID: 32862826 [TBL] [Abstract][Full Text] [Related]
5. [Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center]. Wu A; Wang L; Du C; Peng Y; Yao Y; Zhao J; Zhan T; Cai Y; Li Y; Sun Y; Ji J Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):417-424. PubMed ID: 28440523 [TBL] [Abstract][Full Text] [Related]
6. Outcomes after the watch-and-wait strategy and local excision treatment for rectal cancer: a meta-analysis. Li J; Ma Y; Wen L; Zhang G; Yao X Expert Rev Anticancer Ther; 2023 May; 23(5):555-564. PubMed ID: 36795784 [TBL] [Abstract][Full Text] [Related]
7. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons]. Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634 [No Abstract] [Full Text] [Related]
8. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report]. Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308 [No Abstract] [Full Text] [Related]
9. A meta-analysis of the watch-and-wait strategy versus total mesorectal excision for rectal cancer exhibiting complete clinical response after neoadjuvant chemoradiotherapy. Yu G; Lu W; Jiao Z; Qiao J; Ma S; Liu X World J Surg Oncol; 2021 Oct; 19(1):305. PubMed ID: 34663341 [TBL] [Abstract][Full Text] [Related]
10. [Long-term prognostic analysis on complete/near-complete clinical remission for mid-low rectal cancer after neoadjuvant chemoradiotherapy]. Wang L; Li S; Zhang X; Sun T; Du C; Chen N; Peng Y; Yao Y; Zhan T; Zhao J; Cai Y; Li Y; Wang W; Li Z; Sun Y; Ji J; Wu A Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1240-1248. PubMed ID: 30506534 [TBL] [Abstract][Full Text] [Related]
11. [Application value of colonoscopic assessment in "watch and wait" strategy for mid-lower rectal cancer after neoadjuvant chemoradiotherapy]. Li SJ; Wang L; Zhang XY; Li YH; Li ZW; Wu Q; Sun YS; Wu AW Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jul; 22(7):648-655. PubMed ID: 31302963 [No Abstract] [Full Text] [Related]
12. Survival outcomes of salvage surgery in the watch-and-wait approach for rectal cancer with clinical complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis. Lin W; Wee IJY; Seow-En I; Chok AY; Tan EK Ann Coloproctol; 2023 Dec; 39(6):447-456. PubMed ID: 38185947 [TBL] [Abstract][Full Text] [Related]
13. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. Dossa F; Chesney TR; Acuna SA; Baxter NN Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):501-513. PubMed ID: 28479372 [TBL] [Abstract][Full Text] [Related]
14. Oncological outcomes of local excision compared with radical surgery after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis. Shaikh I; Askari A; Ourû S; Warusavitarne J; Athanasiou T; Faiz O Int J Colorectal Dis; 2015 Jan; 30(1):19-29. PubMed ID: 25367179 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy]. Wang XH; Zhou CJ; Zhang S; Wang QX; Xiao WW; Ding PR; Chen G; Pan ZZ; Zeng ZF; Gao YH Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):266-273. PubMed ID: 32192306 [No Abstract] [Full Text] [Related]
16. Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy. Smith JJ; Strombom P; Chow OS; Roxburgh CS; Lynn P; Eaton A; Widmar M; Ganesh K; Yaeger R; Cercek A; Weiser MR; Nash GM; Guillem JG; Temple LKF; Chalasani SB; Fuqua JL; Petkovska I; Wu AJ; Reyngold M; Vakiani E; Shia J; Segal NH; Smith JD; Crane C; Gollub MJ; Gonen M; Saltz LB; Garcia-Aguilar J; Paty PB JAMA Oncol; 2019 Apr; 5(4):e185896. PubMed ID: 30629084 [TBL] [Abstract][Full Text] [Related]
17. Chemoradiation and consolidation chemotherapy for rectal cancer provides a high rate of organ preservation with a very good long-term oncological outcome: a single-center cohort series. Asoglu O; Bulut A; Aliyev V; Piozzi GN; Guven K; Bakır B; Goksel S World J Surg Oncol; 2022 Nov; 20(1):358. PubMed ID: 36352416 [TBL] [Abstract][Full Text] [Related]
18. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study. Fernandez LM; São Julião GP; Figueiredo NL; Beets GL; van der Valk MJM; Bahadoer RR; Hilling DE; Meershoek-Klein Kranenbarg E; Roodvoets AGH; Renehan AG; van de Velde CJH; Habr-Gama A; Perez RO; Lancet Oncol; 2021 Jan; 22(1):43-50. PubMed ID: 33316218 [TBL] [Abstract][Full Text] [Related]
19. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854 [TBL] [Abstract][Full Text] [Related]
20. [Long-term outcome of patients with rectal cancer who achieve complete or near complete clinical responses after neoadjuvant therapy: a multicenter registry study of data from the Chinese Watch and Wait Database]. Zhao YM; Wang WH; Zhang W; Wang L; Li S; Wang JW; Liao LE; Yu GY; Sun Z; Qu YL; Gong Y; Lu Y; Wu T; Li YF; Wang Q; Zhao GH; Xiao Y; Ding PR; Zhang Z; Wu AW Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):372-382. PubMed ID: 38644243 [No Abstract] [Full Text] [Related] [Next] [New Search]